Skip to content

To compare butorphanol and buprenorphine with levo-bupivacaine for post-operative analgesia

Post-operative analgesia of Butorphanol and Buprenorphine using levo-bupivacaine in Transversus Abdominis Plane Block in lower abdominal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056741
Enrollment
84
Registered
2023-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Butorphanol: Group A will receive 20ml of 0.25% levo-bupivacaine + 1mg (1ml) butorphanol Intervention2: Post-operative analgesia of Butorphanol and Buprenorphine using levo-bupivacaine

Sponsors

Rohilkhand Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II. No other associated cardiovascular/ respiratory disease

Exclusion criteria

Exclusion criteria: Patient with known hypersensitivity to local anaesthetics. Patients with opioids addiction. Patient with any local infection at site.

Design outcomes

Primary

MeasureTime frame
Duration of analgesia Time of First onset of pain and time of first request for analgesia Timepoint: In Postoperative ward, the patient will be assessed for the presence and severity of pain at rest and on movement by VAS, nausea, vomiting and any other side effects at intervals of 2, 4, 6, 8, 12, 24 hours.

Secondary

MeasureTime frame
Hemodynamic and Respiratory stability Any side effects or complications of study drugs and blocks Timepoint: The vitals heart rate NIBP & SPO2 will be recording for 30 minutes and at 2 4 6 8 12 24 hours postoperatively

Countries

India

Contacts

Public ContactDR NEHA CHAUHAN

ROHILKHAND MEDICAL COLLEGE AND HOSPITAL

akku165@gmail.com9935312219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026